Queensland-based AnteoTech has received European accreditation for its 15-minute COVID-19 rapid test, to take the fight on the illness overseas. Their innovative, point-of-care COVID-19 antigen rapid test platform, EuGeni now has Conformitè Europëenne Mark registration, meaning it meets the health and safety rules in both the UK and Europe. The company will now start to commercialise their product in Australia, with the test based on their proprietary binding technology paired with global advancements in assay detection systems. The next step is gaining approval from the TGA in Australia to start the manufacturing process. | https://www.anteotech.com/announcements/test-platform-and-covid-19-test-receive-ce-mark-approval/
Hannah Devlin, Guardian UK Science Correspondent, reports that two US patients have recovered from intractable infections after being treated with a pioneering phage therapy involving genetically engineered bacteria-killing viruses.A 26-year-old man with cystic fibrosis, was approaching death after suffering a chronic lung infection. After being given the phage therapy, his infection cleared allowing him to receive a lung transplant and resume an active life.And, a 56-year-old man with severe arthritis, showed a remarkable recovery from a skin infection that was taking hold of his body and which had proved untreatable with conventional drugs. For more information see: https://www.inkl.com/news/phage-
Lynn Wood
Sabra Brock
